Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for negative symptoms in schizophrenia
NCT00148447Phase 3Completed
- Sponsor
- Beer Yaakov - Ness Ziona Mental Health Center
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of escitalopram in schizophrenia, sponsored by Beer Yaakov - Ness Ziona Mental Health Center. Started Nov 2004; status: completed.
02
Drugs
escitalopram
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00148447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00148447.